Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

The aldosterone antagonist and facultative diuretic eplerenone: a critical review.

Reyes AJ, Leary WP, Crippa G, Maranhão MF, Hernández-Hernández R.

Eur J Intern Med. 2005 Feb;16(1):3-11.

PMID:
15733814
2.

Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.

Dieterich HA, Wendt C, Saborowski F.

Fiziol Cheloveka. 2005 Nov-Dec;31(6):97-105. Review.

PMID:
16366159
3.

Aldosterone receptor antagonists and cardiovascular disease: do we need a change of the guard?

Jewell CW, Watson LE, Mock J, Dostal DE.

Cardiovasc Hematol Agents Med Chem. 2006 Apr;4(2):129-53. Review.

PMID:
16611048
4.

Aldosterone and volume management in hypertensive heart disease.

Sica DA.

Semin Nephrol. 2014 May;34(3):323-32. doi: 10.1016/j.semnephrol.2014.04.007. Epub 2014 Apr 18. Review.

PMID:
25016402
5.

The future of antihypertensive treatment.

Israili ZH, Hernández-Hernández R, Valasco M.

Am J Ther. 2007 Mar-Apr;14(2):121-34. Review.

PMID:
17414579
6.

[The AREA IN-CHF trial (antiremodeling effect of aldosterone receptors blockade with canrenone in mild chronic heart failure): rationale and design].

Cacciatore G, Boccanelli A, Mureddu GF, Maggioni AP, Latini R, Masson S, de Simone G; Investigatori dell' Area In-CHF.

Ital Heart J. 2005 May;6 Suppl 1:66S-74S. Review. Italian.

PMID:
15945301
7.

Update of diuretics in the treatment of hypertension.

Padilla MC, Armas-Hernández MJ, Hernández RH, Israili ZH, Valasco M.

Am J Ther. 2007 Mar-Apr;14(2):154-60. Review.

PMID:
17414583
8.

Are we misunderstanding beta-blockers.

Cruickshank JM.

Int J Cardiol. 2007 Aug 9;120(1):10-27. Epub 2007 Apr 12. Review.

PMID:
17433471
9.

Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?

Bansal S, Lindenfeld J, Schrier RW.

Circ Heart Fail. 2009 Jul;2(4):370-6. doi: 10.1161/CIRCHEARTFAILURE.108.821199. Review.

10.

Aldosterone receptor antagonism in heart failure.

Jennings DL, Kalus JS, O'Dell KM.

Pharmacotherapy. 2005 Aug;25(8):1126-33. Review.

PMID:
16207104
11.
12.

Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension.

Calhoun DA.

J Clin Hypertens (Greenwich). 2007 Jan;9(1 Suppl 1):19-24. Review.

13.

Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.

Ezekowitz JA, McAlister FA.

Eur Heart J. 2009 Feb;30(4):469-77. doi: 10.1093/eurheartj/ehn543. Epub 2008 Dec 9. Review.

PMID:
19066207
15.

Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.

Fortuna P, Reis I, Ascenção R, Carneiro AV.

Rev Port Cardiol. 2008 Jul-Aug;27(7-8):977-89. Review. English, Portuguese.

PMID:
18959094
16.
17.
18.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
19.
20.

New onset diabetes during antihypertensive therapy.

Alderman MH.

Am J Hypertens. 2008 May;21(5):493-9. doi: 10.1038/ajh.2008.17. Epub 2008 Mar 20. Review.

PMID:
18437139

Supplemental Content

Support Center